● Recruiting

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Condition: Lymphoma · Non-Hodgkin Lymphoma · Hodgkin Lymphoma · Sponsor: AstraZeneca

PhasePhase 1/Phase 2

Planned participants161

Who can joinAll sexes, 12 Years to no upper limit

Healthy volunteersNo

About this study

This study is designed to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy following oral administration of AZD3470 as a monotherapy, and in combination with other anticancer agents in participants with haematologic malignancies.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (37)

Research Site	Duarte, California, United States	Not Yet Recruiting
Research Site	Miami, Florida, United States	Recruiting
Research Site	Atlanta, Georgia, United States	Withdrawn
Research Site	Boston, Massachusetts, United States	Recruiting
Research Site	Boston, Massachusetts, United States	Not Yet Recruiting
Research Site	New York, New York, United States	Not Yet Recruiting
Research Site	Philadelphia, Pennsylvania, United States	Recruiting
Research Site	Houston, Texas, United States	Recruiting
Research Site	Adelaide, Australia	Withdrawn
Research Site	Birtinya, Australia	Withdrawn
Research Site	Fitzroy, Australia	Not Yet Recruiting
Research Site	Nedlands, Australia	Recruiting

+ 25 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06137144